2021
DOI: 10.1200/jco.2021.39.15_suppl.e20025
|View full text |Cite
|
Sign up to set email alerts
|

Acute and chronic cancer-related distress among multiple myeloma patients during the COVID-19 pandemic.

Abstract: e20025 Background: Patients with multiple myeloma (MM) are uniquely susceptible to viral and bacterial illnesses. In addition, MM and its treatments lead to immune deficiency, putting patients at a high risk for infection, including the novel coronavirus (COVID-19). The emotional impact of COVID-19 on high-risk groups, such as MM patients, remains unclear. The purpose of this project was to understand psychosocial distress and unmet needs among patients with active MM during the acute and chronic phase of COV… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…22 Therefore, HealthTree Cure Hub practices a patient-input and medical consultant-verified approach to maximize the potential for population-based analyses and to draw reliable conclusions. As a result, we have published nine abstracts, seven to ASCO [23][24][25][26][27][28][29] and two to the American Association of Cancer Research, 30,31 and published one peer-reviewed manuscript in Dermatologic Therapy, 18 with others in preparation.…”
Section: Discussionmentioning
confidence: 99%
“…22 Therefore, HealthTree Cure Hub practices a patient-input and medical consultant-verified approach to maximize the potential for population-based analyses and to draw reliable conclusions. As a result, we have published nine abstracts, seven to ASCO [23][24][25][26][27][28][29] and two to the American Association of Cancer Research, 30,31 and published one peer-reviewed manuscript in Dermatologic Therapy, 18 with others in preparation.…”
Section: Discussionmentioning
confidence: 99%